| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
Istituto di Ricerca sulle Talassemie e Anemie Mediterranee (A.M., V.F., A.C.), Consiglio Nazionale Ricerche, 09121 Cagliari; Unità Operativa di Pediatria (R.P., E.C.), Azienda Ospedaliera Vito Fazzi, 73100 Lecce; and Dipartimento di Scienze Biomediche e Biotecnologie (A.C., M.C.R.) and Dipartimento di Scienze Applicate ai Biosistemi (M.C.R.), Università degli Studi, 09121 Cagliari, Italy
Address all correspondence and requests for reprints to: Maria Cristina Rosatelli, Dipartimento di Scienze Biomediche e Biotecnologie, Via Jenner s/n, 09121 Cagliari, Italy. E-mail: crosatel{at}mcweb.unica.it
Abstract
In this study, we have carried out molecular analysis of the AIRE (autoimmune regulator) gene in 11 patients (from 8 families) affected by autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, originating from a restricted area of Southern Italy (the Salento peninsula in Puglia). Of the 16 mutant AIRE alleles from the 8 probands studied, 12 carried a missense mutation (W78R in 9, P539L in 2, and P252L in 1), 2 carried the Q358X nonsense mutation, and 2 carried the 1058delT frameshift mutation. All these mutations except the 1058delT are novel. Each of the detected mutations either predicts a premature termination of the protein or results in a nonconservative amino acid change, most likely adversely affecting the function of the protein. The W78R missense mutation is relatively common in these patients, having been detected (in homozygosity or compound heterozygosity) in 6 of the 8 probands tested, indicating the presence of a founder effect. The results of this study contribute to the delineation of the molecular pathology of the AIRE gene and enhance our ability to perform a molecular diagnosis in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients from Southern Italy.
This article has been cited by other articles:
![]() |
A. Meloni, M. Furcas, F. Cetani, C. Marcocci, A. Falorni, R. Perniola, M. Pura, A. S. Boe Wolff, E. S. Husebye, D. Lilic, et al. Autoantibodies against Type I Interferons as an Additional Diagnostic Criterion for Autoimmune Polyendocrine Syndrome Type I J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4389 - 4397. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Perry, O. Kecha, J. Paquette, C. Huot, G. Van Vliet, and C. Deal Primary Adrenal Insufficiency in Children: Twenty Years Experience at the Sainte-Justine Hospital, Montreal J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3243 - 3250. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dittmar and G. J. Kahaly Polyglandular Autoimmune Syndromes: Immunogenetics and Long-Term Follow-Up J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 2983 - 2992. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |